TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/21/24 16:30 | 11/21/24 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly John Alexander | NC | O | CFO | P | 20 | 6.76 | 0 | 3 | 9 | 38 | D | ||||||||||||||
10/27/23 16:55 | 8/18/23 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly John Alexander | NC | O | CFO | P.a | 43 | 0.4800 | 0 | 90 | 31 | 383 | D | ||||||||||||||
3/21/23 09:19 | 3/17/23 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly John Alexander | NC | O | CFO | P | 17 | 0.8600 | 0 | 20 | 9 | 246 | D | ||||||||||||||
9/26/22 16:10 | 9/22/22 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly John Alexander | NC | O | CFO | P.m | 60 | 1.32 | 0 | 45 | 38 | 163 | D | ||||||||||||||
6/24/22 08:59 | 6/22/22 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly John Alexander | NC | O | CFO | P | 51 | 1.50 | 0 | 34 | 40 | 118 | D | ||||||||||||||
3/21/22 18:22 | 3/17/22 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly John Alexander | NC | O | CFO | P | 51 | 3.08 | 0 | 17 | 85 | 36 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |